Protein Expression - Global Strategic Business Report

Global Protein Expression Market to Reach $7.1 Billion by 2030

The global market for Protein Expression estimated at US$2.7 Billion in the year 2022, is projected to reach a revised size of US$7.1 Billion by 2030, growing at a CAGR of 13% over the analysis period 2022-2030. Reagents, one of the segments analyzed in the report, is projected to record 13.6% CAGR and reach US$4.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Expression Vectors segment is readjusted to a revised 12.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $789.9 Million, While China is Forecast to Grow at 12.1% CAGR

The Protein Expression market in the U.S. is estimated at US$789.9 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 12.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.7% and 10.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR.

Select Competitors (Total 46 Featured) -

• Batavia Biosciences BV
• Beijing CC-Pharming Ltd.
• BioChain Institute, Inc.
• Biognosys
• Canopy Biosciences, LLC
• Cube Biotech GmbH
• Elabscience Biotechnology Inc.
• ExcellGene
• GenScript Biotech Corporation
• Green Mountain Antibodies

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year